Precision Medicine in Head and Neck Cancer: Myth or Reality?
Standard treatment in head and neck squamous cell carcinoma (HNSCC) is limited currently with decisions being made primarily based on tumor location, histology, and stage. The role of the human papillomavirus in risk stratification is actively under clinical trial evaluations. The molecular complexi...
Main Authors: | Eoghan Malone, Lillian L Siu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-06-01
|
Series: | Clinical Medicine Insights: Oncology |
Online Access: | https://doi.org/10.1177/1179554918779581 |
Similar Items
-
The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality
by: Daris Ferrari, et al.
Published: (2020-01-01) -
Dihydropyrimidine dehydrogenase mutation in neoadjuvant chemotherapy in head and neck cancers: Myth or reality?
by: Vijay M Patil, et al.
Published: (2016-01-01) -
Molecular profiling for precision cancer therapies
by: Eoghan R. Malone, et al.
Published: (2020-01-01) -
Utility of topical tranexamic acid in head-and-neck cancer surgery: A myth or reality?
by: Snehal Shah, et al.
Published: (2020-01-01) -
Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches
by: Giacomo Miserocchi, et al.
Published: (2022-05-01)